Tele-Harm Reduction
Completed · Not applicable
Conditions studied: IV Drug Usage, HIV Infections, Hepatitis C
In brief
The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
Key facts
- Study ID
- NCT05208697
- Run by
- University of Miami
- People needed
- 100
- Starts
- 2022-10-10
- Expected to finish
- 2026-04-30
- Last updated by the study team
- 2026-06-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age 18 or older
- able to speak English
- enrolled in IDEA Miami or IDEA Tampa SSPs
- injection drug use in past 12 months by self-report
- willing and able to sign informed consent, provide locator information and medical records release
- testing reactive for HIV by rapid test
- HIV RNA>200 copies/ml as determined by on-site labs or abstracted medical records (result within 3 months of randomization date)
You may not qualify if…
- testing HIV negative via rapid test
- receipt of THR intervention in the past 6 months
- inability to provide informed consent
- planning to leave the area within 12 months
- Principal or site investigator discretion
- currently in prison or jail
- Enrollment in Clinical Trials Network 121
Where it is running
- Care Resource The SPOT — Fort Lauderdale, Florida, United States
- University of Miami — Miami, Florida, United States
- University of South Florida — Tampa, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.